AIDS practice issues today: interview with Paul Bellman, M.D. Interview by John S. James.
Bellman
P
P
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002331:Carnitine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016527:Drug Costs; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015497:HIV-1; D006297:Health Services Accessibility; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced; D013997:Time Factors
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D002331:Carnitine